Early phase II study of mixed 19‐peptide vaccine monotherapy for refractory triple‐negative breast cancer-Reference-Cited by-同舟云学术

Early phase II study of mixed 19‐peptide vaccine monotherapy for refractory triple‐negative breast cancer

Published:2020-06-25 Issue:8 Volume:111 Page:2760-2769
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Toh Uhi¹^ORCID,Sakurai Sayaka¹,Saku Shuko¹,Takao Yuko¹,Okabe Mina¹,Iwakuma Nobutaka¹,Shichijo Shigeki²^ORCID,Yamada Akira³^ORCID,Itoh Kyogo²,Akagi Yoshito¹

Affiliation:

1. Department of Surgery Kurume University School of Medicine Kurume Japan

2. Cancer Vaccine Center Kurume University School of Medicine Kurume Japan

3. Division of Cancer Vaccine Research Center for Innovative Cancer Therapy Kurume University School of Medicine Kurume Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.14510

Reference27 articles.

1. Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer

2. Time trends of overall survival among metastatic breast cancer patients in the real-life ESME cohort

3. Global analysis of advanced/metastatic breast cancer: Decade report (2005–2015)

4. KEYNOTE-119: Phase III study of pembrolizumab (pembro) versus single-agent chemotherapy (chemo) for metastatic triple negative breast cancer (mTNBC)

5. Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoantigens and cancer-testis antigens as promising vaccine candidates for triple-negative breast cancer: Delivery strategies and clinical trials;Journal of Controlled Release;2024-06

2. Novel immunotherapies for breast cancer: Focus on 2023 findings;International Immunopharmacology;2024-02

3. Peptide Vaccines as Therapeutic and Prophylactic Agents for Female-Specific Cancers: The Current Landscape;Pharmaceuticals;2023-07-24

4. Cancer Vaccines for Triple-Negative Breast Cancer: A Systematic Review;Vaccines;2023-01-09

5. Peptide-Based Vaccines in Clinical Phases and New Potential Therapeutic Targets as a New Approach for Breast Cancer: A Review;Vaccines;2022-08-03